Skip to content

CDR

Walmart changes company’s legal name

Walmart changes company’s legal name

The world’s largest retailer is officially changing its legal name from Wal-Mart Stores Inc. to Walmart Inc. Walmart said Wednesday that the change, which takes effect with the start of its new fiscal year on Feb. 1, is meant to reflect the company’s shift from an operator of stores to one that

RangeMe Verified brands eases ‘business-ready’ sourcing

RangeMe Verified brands eases ‘business-ready’ sourcing

ECRM’s RangeMe has launched RangeMe Verified brands, a new service to help retail buyers to identify “business-ready” products and companies. RangeMe said Wednesday that the RangeMe Verified brands service is designed to make the sourcing the right products less time-consuming for retailers.

Fred’s mulls asset sale, posts bigger 3Q loss

Fred’s mulls asset sale, posts bigger 3Q loss

Fred’s Inc. reported a bigger year-over-year loss for its fiscal 2017 third quarter and plans to cancel its dividend and explore the sale of non-core assets. Fred’s said Wednesday that for the third quarter ended Oct. 28, it reported a net loss of $51.8 million or $1.

Walgreens rebranding embraces old, new

Walgreens rebranding embraces old, new

In an era when brand image all too often oversells what it is supposed to represent, Walgreens finds itself in the enviable position of updating its identity to better reflect its very real merits and the combination of continuity and change that characterizes the drug chain.

HDA: Drug chains still Rx distributors’ biggest customers

HDA: Drug chains still Rx distributors’ biggest customers

Chain drug stores remain the largest customer segment for U.S. pharmaceutical distributors, according to the HDA Research Foundation. The 88th Edition HDA Factbook (2017‐2018) said chain drug retailers accounted for nearly 30% of all sales to drug distributors last year.

Aurora Pharmacy parent agrees to merger deal

Aurora Pharmacy parent agrees to merger deal

Aurora Pharmacy is slated to become part of a much larger organization. Parent Aurora Health Care plans to merge with Advocate Health Care to form Advocate Aurora Health, which the companies said will be the nation’s 10th-largest nonprofit, integrated health care system.

Rite Aid, TV physician promote flu vaccination

Rite Aid, TV physician promote flu vaccination

Rite Aid Corp. has enlisted the help of Dr. Jennifer Caudle, a nationally renowned health expert and practicing family doctor, to highlight the importance of getting a flu shot during National Influenza Vaccination Week (NIVW).

Nestlé to buy Atrium Innovations in $2.3 billion deal

Nestlé to buy Atrium Innovations in $2.3 billion deal

Nestlé plans to acquire nutritional health product maker Atrium Innovations Inc. for $2.3 billion. Plans call for Montreal-based Atrium, which is being purchased from a group of investors led by Permira Funds, to become part of Nestlé Health Science, Nestlé said Tuesday.

Moberg realigns sales and marketing operations

Moberg realigns sales and marketing operations

Moberg Pharma AB is sharpening its focus on the North American marketplace as part of a reorganization of its sales and marketing operations. Moberg said it’s forming a global consumer health sales and marketing unit that includes both direct and distributor sales.

Mega-merger turns spotlight on MinuteClinic

Mega-merger turns spotlight on MinuteClinic

While the changes that CVS Health’s $69 billion deal to buy Aetna may bring to the health care sector remain unclear, it’s very likely that a big beneficiary of deal would be MinuteClinic, says one market researcher.

WBA to buy stake in China’s GuoDa drug chain

WBA to buy stake in China’s GuoDa drug chain

Walgreens Boots Alliance (WBA) plans to pay about $416 million to acquire a 40% stake in Sinopharm Holding GuoDa Drug Store Co. WBA confirmed the deal on Monday. GuoDa is the largest retail pharmacy operator in China, with nearly 3,700 stores.

Canada plans changes to drug pricing rules

Canada plans changes to drug pricing rules

The Canadian government is stepping up efforts to rein in the cost of prescription drugs. At the start of this month, Canada proposed the first major update to the Patented Medicines Regulations in more than 20 years.